SynthesisFrontiers in cardiovascular medicine2024

Comparison of glucagon-like peptide-1 receptor agonists vs. placebo on any cardiovascular events in overweight or obese non-diabetic patients: a systematic review and meta-analysis.

Raveena Kelkar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.